Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECRO: oXiris vs PrismafleX in Septic Shock
NCT03426943Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2018
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoints: Interleukin 6 plasmatic concentration at 24 hours and Endotoxin plasmatic mass concentration at 24 hours. Started Dec 2018; status: completed.
Beyond the preview
Go deeper on NCT03426943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426943.